NeuroBo Pharmaceuticals Ownership 2024 | Who Owns NeuroBo Pharmaceuticals Now?
Institutional Ownership
4.59%
Insider Ownership
66.23%
Retail Ownership
29.18%
Institutional Holders
16.00
NeuroBo Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 1.64% | - | 42,220 | - | - | 29,989,000 | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | 1.29% | 0.00% | 33,327 | 33,327 | 100.00% | 23,672,000 | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | 0.45% | - | 11,642 | -33,787 | -74.37% | 8,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.44% | - | 11,395 | 7,768 | 214.17% | 8,090,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.21% | 0.00% | 5,385 | - | - | 4,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 42 | 18 | 75.00% | 30,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 8 | - | - | 6,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.00% | - | 2 | -2 | -50.00% | 1,000 | Mar 31, 2023 |
| CITIGROUP INC | - | - | - | -4,175 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -100 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -65,035 | -100.00% | - | Mar 31, 2023 |
| ENGINEERS GATE MANAGER LP | - | - | - | -19,693 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -3 | -100.00% | - | Mar 31, 2023 |
| SQUAREPOINT OPS LLC | - | - | - | -24,146 | -100.00% | - | Mar 31, 2023 |
| KINGSVIEW WEALTH MANAGEMENT, LLC | - | - | - | -17,839 | -100.00% | - | Mar 31, 2023 |
| CVI HOLDINGS, LLC | - | - | - | -215,045 | -100.00% | - | Mar 31, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -13,953 | -100.00% | - | Mar 31, 2023 |
| WALLEYE CAPITAL LLC | - | - | - | -95,000 | -100.00% | - | Mar 31, 2023 |
| SABBY MANAGEMENT, LLC | - | - | - | -841,815 | -100.00% | - | Mar 31, 2023 |
NeuroBo Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 1.64% of the company's total share outstanding, currently valued at $29.99M. The top 10 institutional shareholders own together 4.04% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 1.29% | 0.00% | 33,327 | 33,327 | 100.00% | 23,672,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.21% | 0.00% | 5,385 | - | - | 4,000 | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | 0.45% | - | 11,642 | -33,787 | -74.37% | 8,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.44% | - | 11,395 | 7,768 | 214.17% | 8,090,000 | Mar 31, 2023 |
| BLACKROCK INC. | 1.64% | - | 42,220 | - | - | 29,989,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 42 | 18 | 75.00% | 30,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 8 | - | - | 6,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.00% | - | 2 | -2 | -50.00% | 1,000 | Mar 31, 2023 |
| KINGSVIEW WEALTH MANAGEMENT, LLC | - | - | - | -17,839 | -100.00% | - | Mar 31, 2023 |
| SABBY MANAGEMENT, LLC | - | - | - | -841,815 | -100.00% | - | Mar 31, 2023 |
| CITIGROUP INC | - | - | - | -4,175 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -100 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -65,035 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -3 | -100.00% | - | Mar 31, 2023 |
| WALLEYE CAPITAL LLC | - | - | - | -95,000 | -100.00% | - | Mar 31, 2023 |
| ENGINEERS GATE MANAGER LP | - | - | - | -19,693 | -100.00% | - | Mar 31, 2023 |
| SQUAREPOINT OPS LLC | - | - | - | -24,146 | -100.00% | - | Mar 31, 2023 |
| CVI HOLDINGS, LLC | - | - | - | -215,045 | -100.00% | - | Mar 31, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -13,953 | -100.00% | - | Mar 31, 2023 |
The largest NeuroBo Pharmaceuticals shareholder by % of total assets is TWO SIGMA SECURITIES, LLC. The company owns 33.33K shares of NeuroBo Pharmaceuticals (NRBO), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 1.29% | 0.00% | 33,327 | 33,327 | 100.00% | 23,672,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.44% | - | 11,395 | 7,768 | 214.17% | 8,090,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 42 | 18 | 75.00% | 30,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 8 | - | - | 6,000 | Mar 31, 2023 |
| BLACKROCK INC. | 1.64% | - | 42,220 | - | - | 29,989,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.21% | 0.00% | 5,385 | - | - | 4,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.00% | - | 2 | -2 | -50.00% | 1,000 | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -3 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -100 | -100.00% | - | Mar 31, 2023 |
| CITIGROUP INC | - | - | - | -4,175 | -100.00% | - | Mar 31, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -13,953 | -100.00% | - | Mar 31, 2023 |
| KINGSVIEW WEALTH MANAGEMENT, LLC | - | - | - | -17,839 | -100.00% | - | Mar 31, 2023 |
| ENGINEERS GATE MANAGER LP | - | - | - | -19,693 | -100.00% | - | Mar 31, 2023 |
| SQUAREPOINT OPS LLC | - | - | - | -24,146 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | 0.45% | - | 11,642 | -33,787 | -74.37% | 8,000 | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -65,035 | -100.00% | - | Mar 31, 2023 |
| WALLEYE CAPITAL LLC | - | - | - | -95,000 | -100.00% | - | Mar 31, 2023 |
| CVI HOLDINGS, LLC | - | - | - | -215,045 | -100.00% | - | Mar 31, 2023 |
| SABBY MANAGEMENT, LLC | - | - | - | -841,815 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, NeuroBo Pharmaceuticals's largest institutional buyer is TWO SIGMA SECURITIES, LLC. The company purchased 33.33K stocks of NRBO, valued at $23.67M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | - | - | - | -841,815 | -100.00% | - | Mar 31, 2023 |
| CVI HOLDINGS, LLC | - | - | - | -215,045 | -100.00% | - | Mar 31, 2023 |
| WALLEYE CAPITAL LLC | - | - | - | -95,000 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -65,035 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | 0.45% | - | 11,642 | -33,787 | -74.37% | 8,000 | Mar 31, 2023 |
| SQUAREPOINT OPS LLC | - | - | - | -24,146 | -100.00% | - | Mar 31, 2023 |
| ENGINEERS GATE MANAGER LP | - | - | - | -19,693 | -100.00% | - | Mar 31, 2023 |
| KINGSVIEW WEALTH MANAGEMENT, LLC | - | - | - | -17,839 | -100.00% | - | Mar 31, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -13,953 | -100.00% | - | Mar 31, 2023 |
| CITIGROUP INC | - | - | - | -4,175 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -100 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -3 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | 0.00% | - | 2 | -2 | -50.00% | 1,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.21% | 0.00% | 5,385 | - | - | 4,000 | Mar 31, 2023 |
| BLACKROCK INC. | 1.64% | - | 42,220 | - | - | 29,989,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 8 | - | - | 6,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 42 | 18 | 75.00% | 30,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.44% | - | 11,395 | 7,768 | 214.17% | 8,090,000 | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | 1.29% | 0.00% | 33,327 | 33,327 | 100.00% | 23,672,000 | Mar 31, 2023 |
As of Mar 31 2023, NeuroBo Pharmaceuticals's biggest institutional seller is SABBY MANAGEMENT, LLC. The company sold -0.84M shares of NRBO, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 1.29% | 0.00% | 33,327 | 33,327 | 100.00% | 23,672,000 | Mar 31, 2023 |
NeuroBo Pharmaceuticals's largest new institutional shareholder by number of shares is TWO SIGMA SECURITIES, LLC, purchased 33.33K shares, valued at $23.67M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | - | - | - | -841,815 | -100.00% | - | Mar 31, 2023 |
| CVI HOLDINGS, LLC | - | - | - | -215,045 | -100.00% | - | Mar 31, 2023 |
| WALLEYE CAPITAL LLC | - | - | - | -95,000 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -65,035 | -100.00% | - | Mar 31, 2023 |
| SQUAREPOINT OPS LLC | - | - | - | -24,146 | -100.00% | - | Mar 31, 2023 |
| ENGINEERS GATE MANAGER LP | - | - | - | -19,693 | -100.00% | - | Mar 31, 2023 |
| KINGSVIEW WEALTH MANAGEMENT, LLC | - | - | - | -17,839 | -100.00% | - | Mar 31, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -13,953 | -100.00% | - | Mar 31, 2023 |
| CITIGROUP INC | - | - | - | -4,175 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -100 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -3 | -100.00% | - | Mar 31, 2023 |
NeuroBo Pharmaceuticals's largest sold out institutional shareholder by shares sold is SABBY MANAGEMENT, LLC, sold -0.84M shares, valued at -, as of undefined.
NeuroBo Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 815 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 7,183 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 468,960 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 20,396 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 138,519 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 16,028 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 64,950 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 69,589 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 378 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 20,558 | 20,558 | - | Feb 29, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 28,597 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 28,020 | 8,544 | 43.87% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 35 | - | - | Apr 30, 2021 |
| NORTHERN FUNDS | 0.00% | 7,267 | - | - | Mar 28, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,589 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,300 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 146 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 3,197 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,664 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 14,016 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 27,255 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 816 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 5,364 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 111 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 639 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 244 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 3,575 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 7,879 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 1,049 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 729 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 1,902 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 20,928 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 801 | 801 | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 2,425 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 627 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 2,001 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 905 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 130 | 130 | - | Jan 31, 2024 |
NeuroBo Pharmaceuticals's largest mutual fund holder by % of total assets is "DEUTSCHE DWS INVESTMENTS VIT FUNDS", owning 815.00 shares, compromising 0.00% of its total assets.
NeuroBo Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 22 | 16 | 6.67% |
| 31 Mar, 22 | 15 | -16.67% |
| 31 Dec, 21 | 18 | - |
| 30 Sep, 21 | 18 | -37.93% |
| 30 Jun, 21 | 29 | -14.71% |
| 31 Mar, 21 | 34 | 17.24% |
| 31 Dec, 20 | 29 | 16.00% |
| 30 Sep, 20 | 25 | - |
| 30 Jun, 20 | 25 | 127.27% |
| 31 Mar, 20 | 11 | 83.33% |
| 31 Dec, 19 | 6 | - |
As of 30 Jun 22, 16 institutions are holding NeuroBo Pharmaceuticals's shares, representing an increase of 6.67% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 22 | 1,223,591 | -8.13% |
| 31 Mar, 22 | 1,331,901 | -21.22% |
| 31 Dec, 21 | 1,690,568 | 125.74% |
| 30 Sep, 21 | 748,888 | -12.82% |
| 30 Jun, 21 | 858,997 | -42.44% |
| 31 Mar, 21 | 1,492,341 | 94.76% |
| 31 Dec, 20 | 766,231 | 3.69% |
| 30 Sep, 20 | 738,978 | -9.88% |
| 30 Jun, 20 | 819,997 | 264.26% |
| 31 Mar, 20 | 225,114 | 179.22% |
| 31 Dec, 19 | 80,623 | - |
NeuroBo Pharmaceuticals (NRBO) has 1.22M shares outstanding as of 30 Jun 22, down -8.13% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 22 | 4.59% | 18.39% |
| 31 Mar, 22 | 5.00% | 9.36% |
| 31 Dec, 21 | 7.30% | 64.69% |
| 30 Sep, 21 | 3.36% | 22.45% |
| 30 Jun, 21 | 3.87% | 8.12% |
| 31 Mar, 21 | 6.90% | 30.93% |
| 31 Dec, 20 | 4.72% | 23.35% |
| 30 Sep, 20 | 4.50% | 17.78% |
| 30 Jun, 20 | 5.03% | 263.80% |
| 31 Mar, 20 | 1.38% | 564.65% |
| 31 Dec, 19 | 0.49% | - |
As of 30 Jun 22, NeuroBo Pharmaceuticals is held by 4.59% institutional shareholders, representing a 18.39% growth compared to 31 Mar 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 22 | 5 | -16.67% |
| 31 Mar, 22 | 6 | -14.29% |
| 31 Dec, 21 | 7 | - |
| 30 Sep, 21 | 7 | -53.33% |
| 30 Jun, 21 | 15 | -25.00% |
| 31 Mar, 21 | 20 | 25.00% |
| 31 Dec, 20 | 16 | 77.78% |
| 30 Sep, 20 | 9 | -59.09% |
| 30 Jun, 20 | 22 | 175.00% |
| 31 Mar, 20 | 8 | 33.33% |
| 31 Dec, 19 | 6 | - |
5 institutional shareholders have increased their position in NRBO stock as of 30 Jun 22 compared to 6 in the previous quarter (a -16.67% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 22 | 4 | -33.33% |
| 31 Mar, 22 | 6 | 50.00% |
| 31 Dec, 21 | 4 | -33.33% |
| 30 Sep, 21 | 6 | -40.00% |
| 30 Jun, 21 | 10 | 66.67% |
| 31 Mar, 21 | 6 | -14.29% |
| 31 Dec, 20 | 7 | -30.00% |
| 30 Sep, 20 | 10 | 400.00% |
| 30 Jun, 20 | 2 | - |
| 31 Mar, 20 | 2 | - |
| 31 Dec, 19 | - | - |
4 institutional shareholders have reduced their position in NRBO stock as of 30 Jun 22 compared to 6 in the previous quarter (a -33.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 22 | 16 | 6.67% | 1,223,591 | -8.13% | 4.59% | 18.39% | 5 | -16.67% | 4 | -33.33% |
| 31 Mar, 22 | 15 | -16.67% | 1,331,901 | -21.22% | 5.00% | 9.36% | 6 | -14.29% | 6 | 50.00% |
| 31 Dec, 21 | 18 | - | 1,690,568 | 125.74% | 7.30% | 64.69% | 7 | - | 4 | -33.33% |
| 30 Sep, 21 | 18 | -37.93% | 748,888 | -12.82% | 3.36% | 22.45% | 7 | -53.33% | 6 | -40.00% |
| 30 Jun, 21 | 29 | -14.71% | 858,997 | -42.44% | 3.87% | 8.12% | 15 | -25.00% | 10 | 66.67% |
| 31 Mar, 21 | 34 | 17.24% | 1,492,341 | 94.76% | 6.90% | 30.93% | 20 | 25.00% | 6 | -14.29% |
| 31 Dec, 20 | 29 | 16.00% | 766,231 | 3.69% | 4.72% | 23.35% | 16 | 77.78% | 7 | -30.00% |
| 30 Sep, 20 | 25 | - | 738,978 | -9.88% | 4.50% | 17.78% | 9 | -59.09% | 10 | 400.00% |
| 30 Jun, 20 | 25 | 127.27% | 819,997 | 264.26% | 5.03% | 263.80% | 22 | 175.00% | 2 | - |
| 31 Mar, 20 | 11 | 83.33% | 225,114 | 179.22% | 1.38% | 564.65% | 8 | 33.33% | 2 | - |
| 31 Dec, 19 | 6 | - | 80,623 | - | 0.49% | - | 6 | - | - | - |
NeuroBo Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of NeuroBo Pharmaceuticals's stock was made by Kim Hyung Heon on Aug 13 2024, selling 11,467 shares at $3.60 per share (valued at $41.28K). The last insider buy of NRBO was made by DONG-A ST CO., LTD on Jul 10 2024, buying 2,544,530 shares at $3.93 per share (worth $10.00M).
NeuroBo Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | 8 | - | - |
| Q1 2024 | 1 | - | - |
| Q4 2023 | 2 | - | - |
| Q3 2023 | 13 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | 1 | 2 | 50.00% |
| Q2 2022 | 10 | - | - |
| Q1 2022 | 1 | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 1 | - | - |
| Q4 2020 | 2 | - | - |
| Q3 2020 | 1 | - | - |
| Q1 2020 | 6 | - | - |
| Q4 2019 | 7 | 5 | 140.00% |
| Q3 2019 | 6 | - | - |
| Q2 2018 | 2 | - | - |
| Q1 2018 | 11 | - | - |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by NeuroBo Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | 2 | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
| Q2 2018 | - | - | - |
| Q1 2018 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of NeuroBo Pharmaceuticals's stocks.
NeuroBo Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| BDRX | Biodexa Pharmaceuticals Plc |
| BWV | Onconetix, Inc. |
| KPRX | Kiora Pharmaceuticals, Inc. |
| PXMD | PaxMedica, Inc. Common Stock |
| PHIO | Phio Pharmaceuticals Corp. |
| REVB | Revelation Biosciences, Inc. |
| QNRX | Quoin Pharmaceuticals, Ltd. |
| HILS | Tharimmune, Inc. |
| VRAX | Virax Biolabs Group Limited |
| ALLR | Allarity Therapeutics, Inc. |
| SONN | Sonnet BioTherapeutics Holdings, Inc. |
| ZURA | Zura Bio Limited |
| CDIO | Cardio Diagnostics Holdings, Inc. |
| ATNF | 180 Life Sciences Corp. |
NRBO Ownership FAQ
Who Owns NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals is owned by institutional shareholders (4.59%), insiders (66.23%), and public (29.18%). The largest institutional shareholder of NeuroBo Pharmaceuticals is BLACKROCK INC. (1.64% of total shares) and the top mutual fund owner is DEUTSCHE DWS INVESTMENTS VIT FUNDS (0.00% of total shares).
Who are the major institutional shareholders of NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals's major institutional shareholders are BLACKROCK INC., TWO SIGMA SECURITIES, LLC, MILLENNIUM MANAGEMENT LLC, UBS GROUP AG, and TOWER RESEARCH CAPITAL LLC (TRC). The top five shareholders own together 4.04% of the company's share outstanding.
How many NeuroBo Pharmaceuticals shareholders are there?
As of Jun 2022, there are 16 institutional shareholders of NeuroBo Pharmaceuticals.
What percentage of NeuroBo Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC owns 42.22K shares of NeuroBo Pharmaceuticals, representing 1.64% of the company's total shares outstanding, valued at $29.99M (as of Mar 2023).
What percentage of NeuroBo Pharmaceuticals is owned by TWO SIGMA SECURITIES, LLC?
As of Mar 2023, TWO SIGMA SECURITIES, LLC holds 33.33K shares of NeuroBo Pharmaceuticals (NRBO), compromising 1.29% of the company, valued at $23.67M.
What percentage of NeuroBo Pharmaceuticals is owned by MILLENNIUM MANAGEMENT LLC?
MILLENNIUM MANAGEMENT LLC is the third largest holder of NeuroBo Pharmaceuticals. The company owns 11.64K of the company's shares outstanding (worth $8K).